1-7 of 7
Yanping Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Efficacy and Safety of the CK1ε/PI3Kδ Dual Inhibitor HZ-H08905 in Patients with Relapsed and/or Refractory Peripheral T-Cell Lymphomas: Results from the Phase 1 HZ-H08905-101 Study

Juying Wei, Wenjuan Yu, Zhengming Jin, Keshu Zhou, Haiyan Yang, Fei Li, Lanfang Li, Bo Zhang, Miao Hu, Yanping Zhang, Xinglu Zhou, Jie Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 3057.
https://doi.org/10.1182/blood-2024-201210
Published: 2024
Journal Articles

Preliminary Efficacy and Safety of the CK1ε/PI3Kδ Dual Inhibitor HZ-H08905 in Patients with Relapsed and/or Refractory B-Cell Lymphomas: Results from the Phase 1 HZ-H08905-101 Study

Juying Wei, Wenjuan Yu, Zhengming Jin, Keshu Zhou, Haiyan Yang, Fei Li, Lanfang Li, Bo Zhang, Miao Hu, Yanping Zhang, Xinglu Zhou, Jie Jin
Journal: Blood
Blood (2024) 144 (Supplement 1): 3015.
https://doi.org/10.1182/blood-2024-201190
Published: 2024
Journal Articles

Preliminary Efficacy and Safety of Bruton Tyrosine Kinase (BTK) Inhibitor HZ-a-018 in Adult Patients with Relapsed and/or Refractory(R/R)Central Nervous System Lymphoma, Results from the Phase Ia Monotherapy of HZ-a-018-102 Study

Wenbin Li, Zhuang Kang, Feng Chen, Shenglan Li, Xi Chen, Xianggui Yuan, Haiyan Yang, Wenbin Qian, Miao Hu, Yanping Zhang, Xinglu Zhou
Journal: Blood
Blood (2024) 144 (Supplement 1): 6510.
https://doi.org/10.1182/blood-2024-201137
Published: 2024
Journal Articles

Preliminary Efficacy and Safety of Bruton Tyrosine Kinase (BTK) Inhibitor HZ-a-018 in Adult Patients with Relapsed and/or Refractory (R/R) Central Nervous System Lymphoma or Treatment-Naïve (TN) Central Nervous System Lymphoma, Results from the Phase Ib Combination Part of HZ-a-018-102 Study

Wenbin Li, Zhuang Kang, Feng Chen, Shenglan Li, Xi Chen, Xianggui Yuan, Haiyan Yang, Wenbin Qian, Miao Hu, Yanping Zhang, Xinglu Zhou
Journal: Blood
Blood (2024) 144 (Supplement 1): 6482.
https://doi.org/10.1182/blood-2024-201166
Published: 2024
Journal Articles

Preclinical and First-in-Human Phase I Study of Bruton Tyrosine Kinase Degrader HZ-Q1070 in Patients with Recurrent or Refractory B-Cell Malignancies

Yuqin Song, Ningjing Lin, Xingguo Liu, Yubo Zhou, Yizhe Wu, Xiaomin Luo, Jiangfeng Xie, Xinna Ma, Miao Hu, Yanping Zhang, Jia Li, Xinglu Zhou
Journal: Blood
Blood (2024) 144 (Supplement 1): 6286.
https://doi.org/10.1182/blood-2024-200544
Published: 2024
Journal Articles

Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop Bone Marrow Failure

Takuya Kamio, MDPhD, Bai-wei Gu, MDPhD, Timothy S. Olson, MDPhD, Yanping Zhang, PhD, Philip J Mason, PhD, Monica Bessler, MDPhD
Journal: Blood
Blood (2014) 124 (21): 4381.
https://doi.org/10.1182/blood.V124.21.4381.4381
Published: 2014
Journal Articles

Human regulatory T cells induce T-lymphocyte senescence

Jian Ye, Xingxu Huang, Eddy C. Hsueh, Qunyuan Zhang, Chunling Ma, Yanping Zhang, Mark A. Varvares, Daniel F. Hoft, Guangyong Peng
Journal: Blood
Blood (2012) 120 (10): 2021–2031.
https://doi.org/10.1182/blood-2012-03-416040
Published: 2012
Includes: Supplemental data